CRYPTOSTAR CORP (CSTR.CA)

CA22905W1095 - Common Stock

0.025  0 (0%)

Fundamental Rating

1

Taking everything into account, CSTR scores 1 out of 10 in our fundamental rating. CSTR was compared to 14 industry peers in the IT Services industry. CSTR has a bad profitability rating. Also its financial health evaluation is rather negative. CSTR does not seem to be growing, but still is valued expensively.



0

1. Profitability

1.1 Basic Checks

CSTR had negative earnings in the past year.
CSTR had a negative operating cash flow in the past year.
In the past 5 years CSTR always reported negative net income.
CSTR had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

With a Return On Assets value of -28.80%, CSTR is not doing good in the industry: 69.23% of the companies in the same industry are doing better.
The Return On Equity of CSTR (-50.00%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -28.8%
ROE -50%
ROIC N/A
ROA(3y)-45.79%
ROA(5y)-40.82%
ROE(3y)-71.24%
ROE(5y)-82.5%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

CSTR does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

3

2. Health

2.1 Basic Checks

CSTR does not have a ROIC to compare to the WACC, probably because it is not profitable.
CSTR has about the same amout of shares outstanding than it did 1 year ago.
CSTR has more shares outstanding than it did 5 years ago.
CSTR has a worse debt/assets ratio than last year.

2.2 Solvency

CSTR has an Altman-Z score of -3.68. This is a bad value and indicates that CSTR is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -3.68, CSTR is doing worse than 61.54% of the companies in the same industry.
A Debt/Equity ratio of 0.34 indicates that CSTR is not too dependend on debt financing.
CSTR has a Debt to Equity ratio of 0.34. This is in the better half of the industry: CSTR outperforms 69.23% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF N/A
Altman-Z -3.68
ROIC/WACCN/A
WACC9.67%

2.3 Liquidity

A Current Ratio of 1.53 indicates that CSTR should not have too much problems paying its short term obligations.
CSTR's Current ratio of 1.53 is fine compared to the rest of the industry. CSTR outperforms 76.92% of its industry peers.
A Quick Ratio of 1.43 indicates that CSTR should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.43, CSTR is doing good in the industry, outperforming 69.23% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.53
Quick Ratio 1.43

0

3. Growth

3.1 Past

CSTR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 78.16%, which is quite impressive.
Looking at the last year, CSTR shows a very negative growth in Revenue. The Revenue has decreased by -20.01% in the last year.
The Revenue for CSTR have been decreasing by -24.73% on average. This is quite bad
EPS 1Y (TTM)78.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%62.82%
Revenue 1Y (TTM)-20.01%
Revenue growth 3Y93.01%
Revenue growth 5Y-24.73%
Sales Q2Q%-60.92%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

CSTR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CSTR!.
Industry RankSector Rank
Dividend Yield N/A

CRYPTOSTAR CORP

TSX-V:CSTR (1/14/2025, 7:00:00 PM)

0.025

0 (0%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)04-26 2024-04-26/amc
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap11.10M
Analysts45.71
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.58
P/FCF N/A
P/OCF N/A
P/B 1.26
P/tB 1.32
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0.01
BVpS0.02
TBVpS0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -28.8%
ROE -50%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-45.79%
ROA(5y)-40.82%
ROE(3y)-71.24%
ROE(5y)-82.5%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.53
Quick Ratio 1.43
Altman-Z -3.68
F-Score6
WACC9.67%
ROIC/WACCN/A
Cap/Depr(3y)110.17%
Cap/Depr(5y)70.44%
Cap/Sales(3y)104.65%
Cap/Sales(5y)81.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)78.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%62.82%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-20.01%
Revenue growth 3Y93.01%
Revenue growth 5Y-24.73%
Sales Q2Q%-60.92%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y70.6%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y93.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y84.87%
OCF growth 3YN/A
OCF growth 5YN/A